We’re excited to keep you up to date on our activities through announcements, but you can also follow us on our social media channels to hear the latest news as it happens.
10 May 2023 | |
04 Apr 2023 | Idorsia Files Petition with the Drug Enforcement Administration (DEA) Urging Them to De-Schedule Dual Orexin Receptor Antagonist Class of Insomnia Medications |
29 Nov 2022 | Insomnia Extends Beyond the Bedroom: Survey Finds That Trouble Sleeping Can Lead to Rocky Relationships |
09 Nov 2022 | Idorsia Announces its Insomnia Medication, QUVIVIQ (daridorexant), is now Covered by TRICARE |
19 Jul 2022 | |
23 Jun 2022 | |
06 Jun 2022 | |
23 May 2022 | |
13 May 2022 | |
02 May 2022 | |
05 Apr 2022 | |
16 Mar 2022 | |
20 Jan 2022 |
The Lancet Neurology reports impact of daridorexant in insomnia |
12 Jan 2022 | Jennifer Aniston partners with Idorsia U.S. to launch ‘Seize the Night & Day’ campaign inspiring Americans to understand their relationship with sleep |
10 Jan 2022 | Idorsia receives US FDA approval of QUVIVIQ (daridorexant) 25 and 50 mg for the treatment of adults with insomnia |
17 Nov 2021 | Idorsia Convenes The Alliance for Sleep, a Force for Innovation and Change in the Insomnia Space |